Johns Hopkins Pathology Johns Hopkins Pathology Johns Hopkins Pathology Johns Hopkins Pathology Johns Hopkins Pathology Johns Hopkins Pathology Johns Hopkins Pathology Johns Hopkins Pathology

Pathology at Johns Hopkins

The Department of Pathology at Johns Hopkins is preeminent nationally and globally in the study and treatment of human disease, and in professional training in all areas of pathology and laboratory science. Currently, there are over 1400 people in the department which includes approximately 120 full-time faculty, 34 residents, 45 graduate students, over 100 fellows, and approximately 1000 staff members.

Read the Pathology Blog


America's Best Hospitals 2010-11, 2013

The Johns Hopkins Hospital is the only hospital in history to have earned the number one ranking for 22 years from U.S. News & World Report and an unprecedented 21 years in a row from 1991 to 2011, and 2013.

For a complete list of all rankings, go to or visit


More Speed Dating for Research

Twenty-two faculty members from the Department of Pathology held a "speed dating for research" event with 22 staff members from the Applied Physics Lab. The goal of the event was to foster research collaborations between the two groups. As you can see from the photos below, the event was simply a wonderful success. Both Pathology and the APL look forward to many years of fruitful collaborations!

New Neuroendocrine Tumor Web Page!

We have launched a new web page dedicated to neuroendocrine tumors (click here). This web page is not organ specific, but instead provides educational information for patients and their families on neuroendocrine tumors of all organs. These tumors include medullary carcinoma of the thyroid, carcinoid tumors of the lung, islet cell tumors of the pancreas, carcinoid tumors of the bowel, and even neuroendocrine tumors of the skin. We encourage you to visit the site and spread the word.

More pathology news >>


Loadng Blog Feeds

More Blogs >>

Pathology Grand Rounds

Current Year | Archives
Deciphering Oncogenic Driver Pathways in Lung Cancer: Implementing Personalized Cancer Therapies into the German Health Care System
Reinhard B├╝ttner, M.D.
Find Person: